Clinical and Antimicrobial Susceptibility Data of 140 Streptococcus pseudopneumoniae Isolates in France | Zendy

C. Laurens | Zendy; Anne-Laure Michon | Zendy; Hélène Marchandin | Zendy; J. Bayette | Zendy; M.-N. Didelot | Zendy; Hélène JeanPierre | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical and Antimicrobial Susceptibility Data of 140 Streptococcus pseudopneumoniae Isolates in France

Author(s) -

C. Laurens,

Anne-Laure Michon,

Hélène Marchandin,

J. Bayette,

M.-N. Didelot,

Hélène JeanPierre

Publication year - 2012

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.06374-11

Subject(s) - erythromycin , penicillin , microbiology and biotechnology , pneumonia , tetracycline , antimicrobial , streptococcus pneumoniae , antibiotics , streptococcus , medicine , biology , bacteria , genetics

We report retrospective analysis of the clinical and antimicrobial susceptibility data of 140Streptococcus pseudopneumoniae isolates. Strains were isolated mostly from respiratory tract samples from patients with underlying diseases. In the case of infection, pneumonia, mainly aspiration pneumonia, was the most frequent (27.1% of the patients). We documented high rates of decreased susceptibilities and resistance to erythromycin and tetracycline (57% and 43% of the isolates, respectively), as well as reduced susceptibility to penicillin in 21% of the isolates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research